“The general pattern, Dr. Hirsch-Ginsberg says, is that diagnostic tools often stay investigational for a long time before they’re as widely used as they could be. But she and Dr. Peerschke express confidence in the Sysmex advanced parameters’ robustness and their ability to diagnose or rule out hematologic conditions in many populations—the complex cancer population being one of the most important.” – write Anne Paxton for CAP Today
Read the entire article here.